J
Jeong Sun Yang
Researcher at Centers for Disease Control and Prevention
Publications - 22
Citations - 2065
Jeong Sun Yang is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 10 publications receiving 1224 citations.
Papers
More filters
Journal ArticleDOI
The Architecture of SARS-CoV-2 Transcriptome.
TL;DR: Functional investigation of the unknown transcripts and RNA modifications discovered in this study will open new directions to the understanding of the life cycle and pathogenicity of SARS-CoV-2.
Journal ArticleDOI
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.
Cheol-Min Kim,Dong Kyun Ryu,Jihun Lee,Young-Il Kim,Ji Min Seo,Yeon Gil Kim,Jae Hee Jeong,Minsoo Kim,Jong-In Kim,Pankyeom Kim,Jin Soo Bae,Eun Yeong Shim,Min Seob Lee,Man Su Kim,Hanmi Noh,Geun Soo Park,Jae Sang Park,Dain Son,Yongjin An,Jeong No Lee,Ki Sung Kwon,Joo Yeon Lee,Hansaem Lee,Jeong Sun Yang,Kyung Chang Kim,Sung Soon Kim,Hye Min Woo,Jun Won Kim,Man Seong Park,Kwang-Min Yu,Se Mi Kim,Eun-Ha Kim,Su-Jin Park,Su-Jin Park,Seong Tae Jeong,Chi Ho Yu,Youngjo Song,Se Hun Gu,Hanseul Oh,Bonsang Koo,Jung Joo Hong,Choong-Min Ryu,Wan Beom Park,Myoung Don Oh,Young Ki Choi,Soo Young Lee +45 more
TL;DR: In this article, human monoclonal antibodies targeting the receptor binding domain (RBD) of the viral spike protein via antibody library constructed from peripheral blood mononuclear cells of a convalescent patient.
Posted ContentDOI
The architecture of SARS-CoV-2 transcriptome
TL;DR: A high-resolution map of the SARS-CoV-2 transcriptome and epitranscriptome is provided using nanopore direct RNA sequencing and DNA nanoball sequencing, finding at least 41 potential RNA modification sites with an AAGAA motif.
Journal ArticleDOI
Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19.
Ji Yun Noh,Jeong-Eun Kwak,Jeong Sun Yang,Soon Young Hwang,Jin Gu Yoon,Hye Seong,Hakjun Hyun,Chae Seung Lim,Soo Young Yoon,Jungsang Ryou,Joo Yeon Lee,Sung Soon Kim,Su-Hyung Park,Hee Jin Cheong,Woo Joo Kim,Eui-Cheol Shin,Joon Young Song +16 more
TL;DR: Most (> 85%) patients carries NAb until six months after diagnosis of SARS-CoV-2 infection, providing insights for establishing vaccination strategies against COVID-19.
Journal ArticleDOI
Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS‐CoV‐2 infection
Hark Kyun Kim,Jun-Shik Cho,Eunae Kim,Junsik Kim,Jeong Sun Yang,Kyung-Chang Kim,Joo Yeon Lee,Younmin Shin,Leon F. Palomera,Jinsu Park,Seung Hyun Baek,Han-Gyu Bae,Yoon Suk Cho,Jihoon Han,Jae Hoon Sul,Jongmin Lee,Jae Hyung Park,Yong Woo Cho,Wonsik Lee,Dong-Gyu Jo +19 more
TL;DR: Therapeutic efficacy of the engineered sEVs against SARS‐CoV‐2 challenge was confirmed using K18‐hACE2 mice and provide opportunities for the development of new s EVs‐based antiviral therapeutics.